Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Xinxing Pharmaceutical Development is a China-based pharmaceutical research and development company headquartered in Hefei, Anhui Province. Founded in 2001, the firm specializes in the discovery and development of small molecule drugs, including both innovative new chemical entities and high-end generic medications. The company provides comprehensive R&D services such as drug synthesis, formulation research, and technical transfer to pharmaceutical manufacturers. Anhui Xinxing focuses on several key therapeutic areas, including cardiovascular diseases, metabolic disorders, and anti-infectives. It operates as a key player in the regional pharmaceutical innovation ecosystem, supporting the modernization of drug production and consistency evaluation in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 安徽省新星药物开发.